A U.S. health advisory panel endorsed booster shots for Moderna’s COVID-19 vaccine, voting to recommend a lower-dose shot for seniors and other high-risk groups. But it stressed there's no evidence it's time to open booster doses to everybody. (Oct. 14)
Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting
- Business Insider
This table shows the important differences between COVID-19 vaccines from Pfizer-BioNTech, Moderna, Johnson & Johnson, and AstraZeneca.
The U.S. Centers for Disease Control and Prevention (CDC) on Thursday said individuals who qualify could choose a different vaccine from the one they received for their initial inoculation. The CDC now recommends that everyone 18 and older who got the Johnson & Johnson vaccine at least two months earlier should receive any one of the authorized COVID-19 boosters. Those who got either of the messenger RNA (mRNA) vaccines from Pfizer/BioNTech or Moderna who are 65 or older are eligible for a booster.
Check Your Medicine Cabinet: Blood Pressure Medications Recalled Over Potential Cancer-Causing Ingredients
Lupin Pharmaceuticals is recalling all Irbesartan tablets and Irbesartan and Hydrochlorothiazide tablets, which might have carcinogenic impurities.
- National Review
CDC Director: ‘We May Need to Update our Definition of Fully Vaccinated’ as Booster Eligibility Increases
Director Rochelle Walensky said that the U.S. may need to amend its definition of “fully vaccinated” as more Americans become eligible to receive booster shots.
- E! News
Christina Haack is hoping to get to the bottom of her renewed stomach pain. The Flip or Flop star shared all of the testing she's recently gone through to solve her current ailment.
- CBS News
Up to 99 million Americans are now eligible for an additional dose.
The mother of two also claims that the milk helps her fiancé's health—but is that entirely true? Here's what the science says.
- CBS News
The analysis was posted late Friday ahead of a meeting of the agency's vaccine advisers to discuss the benefits and risks of vaccinating younger children.
SINGAPORE (Reuters) -Few are left to inoculate in wealthy Singapore after a vigorous campaign achieved a level of coverage envied by many nations battling the coronavirus pandemic, but a record surge in deaths and infections gives warning of risks that may still lie ahead. Despite mask mandates, strict social curbs and COVID-19 booster doses available for over a month, infections in the Asian city-state's latest outbreak, driven by the Delta variant, took the death toll to 280, up from 55 early in September. "Singapore may potentially experience two to three epidemic waves as measures are increasingly relaxed," said Alex Cook, a disease modelling expert at the National University of Singapore (NUS).
- The Conversation
Discuss with your doctor whether or not you need a booster – and if so, which vaccine will work best for you. Justin Sullivan/Getty Images News via Getty ImagesMany Americans now have the green light to get a COVID-19 vaccine booster – and the flexibility to receive a different brand than the original vaccine they received. On the heels of the Food and Drug Administration’s Sept. 22, 2021, emergency use authorization of a third dose – or “booster shot” – of the Pfizer/BioNtech vaccine for certai
- American City Business Journals
The FDA approval comes as Genentech and parent Roche face generic competition for Lucentis and other companies pursue longer-acting drugs for wet AMD patients.
"I told him I have a serious medical condition," recounted state Sen. Tina Polsky, who has been diagnosed with breast cancer.
The U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) has recommended the booster dose of Moderna, Inc.’s (MRNA) COVID-19 vaccine. The dose provided by the American pharmaceutical and biotechnology company can be administered at the 50 µg level to people aged 65 and above, adults (aged 18 to 64) who are at a high risk of severe COVID-19, and people (aged 18 to 64) with frequent occupational exposure to SARS-CoV-2, the company said. The re
- Business Insider
Walmart offers employees a more 'flexible' way of working, asking them to return to the office next month
Walmart's decision comes as many companies grapple with whether to make a return to the office mandatory for employees who transitioned to remote work early in the pandemic.
- The Conversation
Parents were fine with sweeping school vaccination mandates five decades ago – but COVID-19 may be a different story
Children and parents lined up for polio vaccines outside a Syracuse, New York school in 1961. AP PhotoThe ongoing battles over COVID-19 vaccination in the U.S. are likely to get more heated when the Food and Drug Administration authorizes emergency use of a vaccine for children ages 5 to 11, expected later this fall. California has announced it will require the vaccine for elementary school attendance once it receives full FDA approval after emergency use authorization, and other states may foll
- Washington Post
Jennifer Lopez, 58, had jumped at the chance to get the Johnson & Johnson vaccine last March, but soon began feeling regret when data showed it might be less effective than other coronavirus vaccines. So, when the Centers for Disease Control and Prevention signed off on booster shots Thursday night for all Johnson & Johnson recipients who had gone two months since their shot, Lopez wasted no time seeking one out.Subscribe to The Post Most newsletter for the most important and interesting stories
Germany recorded the highest incidence of coronavirus infections since mid-May on Saturday, reaching the threshold of 100 cases per 100,000 in the past seven days that used to be the yardstick for imposing a strict lockdown. However, Health Minister Jens Spahn noted that Germany could cope much better now due to vaccination, although he said restrictions like mask wearing and limits on indoor activity for unvaccinated people would stay until next spring. The seven-day incidence rate of cases - which until August was used to decide whether to impose more stringent COVID-19 curbs - rose to 100 on Saturday from 95 on Friday, the Robert Koch Institute responsible for disease control said.
- Business Insider
People who've had COVID-19 are facing memory problems months after contracting the disease, new study says: 'They can't think'
One of the longterm effects of COVID-19 is "brain fog," or difficulty thinking and concentrating, according to the CDC's website.
- Good Morning America
There is a growing sense of optimism across the country, with national coronavirus infection rates steadily falling, booster shots available for many Americans and pending vaccine approval on the horizon for young children. In southern states like Florida, Mississippi, Louisiana and Georgia, which were hit early on by the delta surge, hospitalizations are on the decline. "You're starting to see an uptick in cases in the colder parts of the country and as people are driven indoors without masks on," former Food and Drug Administration Commissioner Dr. Scott Gottlieb told CNN earlier this month.
(Reuters) -Roche Holding AG on Friday won approval from the U.S. health regulator for its eye implant to treat a chronic disorder causing blurred vision, giving patients an alternative to receiving monthly eye injections with existing treatments. The surgically implantable device Susvimo is intended to treat wet age-related macular degeneration (wet AMD), a disorder caused by the leak of fluid or blood from abnormal blood vessels into an area near the retina called the macula. The device is designed to continuously deliver a customized version of the Swiss company's drug ranibizumab, branded as Lucentis, which is an anti-vascular endothelial growth factor (anti-VEGF) therapy.